1. Home
  2. PACB vs GMRE Comparison

PACB vs GMRE Comparison

Compare PACB & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • GMRE
  • Stock Information
  • Founded
  • PACB 2000
  • GMRE 2011
  • Country
  • PACB United States
  • GMRE United States
  • Employees
  • PACB N/A
  • GMRE N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • GMRE Real Estate Investment Trusts
  • Sector
  • PACB Industrials
  • GMRE Real Estate
  • Exchange
  • PACB Nasdaq
  • GMRE Nasdaq
  • Market Cap
  • PACB 568.0M
  • GMRE 525.1M
  • IPO Year
  • PACB 2010
  • GMRE N/A
  • Fundamental
  • Price
  • PACB $1.64
  • GMRE $7.97
  • Analyst Decision
  • PACB Buy
  • GMRE Strong Buy
  • Analyst Count
  • PACB 13
  • GMRE 2
  • Target Price
  • PACB $2.92
  • GMRE $10.88
  • AVG Volume (30 Days)
  • PACB 9.1M
  • GMRE 730.8K
  • Earning Date
  • PACB 02-13-2025
  • GMRE 02-25-2025
  • Dividend Yield
  • PACB N/A
  • GMRE 10.54%
  • EPS Growth
  • PACB N/A
  • GMRE N/A
  • EPS
  • PACB N/A
  • GMRE N/A
  • Revenue
  • PACB $173,147,000.00
  • GMRE $136,585,000.00
  • Revenue This Year
  • PACB N/A
  • GMRE N/A
  • Revenue Next Year
  • PACB $21.56
  • GMRE $4.89
  • P/E Ratio
  • PACB N/A
  • GMRE N/A
  • Revenue Growth
  • PACB 2.14
  • GMRE N/A
  • 52 Week Low
  • PACB $1.16
  • GMRE $7.33
  • 52 Week High
  • PACB $7.50
  • GMRE $10.58
  • Technical
  • Relative Strength Index (RSI)
  • PACB 37.69
  • GMRE 48.93
  • Support Level
  • PACB $1.59
  • GMRE $7.33
  • Resistance Level
  • PACB $2.22
  • GMRE $7.77
  • Average True Range (ATR)
  • PACB 0.17
  • GMRE 0.22
  • MACD
  • PACB -0.04
  • GMRE 0.08
  • Stochastic Oscillator
  • PACB 7.94
  • GMRE 76.34

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

Share on Social Networks: